Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States.

NPJ Breast Cancer · 2026 · PMC12996327 · PMID 41577681

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

There was a trend toward lower AKT1 mutations in Black patients, but this did not reach statistical significance (4% vs. 7%, p = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.